ANECITA FADOL: Open Payments
NPI 1346338548 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,458 in 5 payments from 4 companies in 2025. Trend: 2023 $457 · 2024 $1,329 · 2025 $4,458
Speaker / faculty: $4,250Food & beverage: $208
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $4,250 |
| ABBVIE INC. | 1 | $109 |
| Amgen Inc. | 2 | $66 |
| BridgeBio Pharma, Inc. | 1 | $34 |
Products named: ICLUSIG, EPKINLY, KRYSTEXXA, Attruby, REPATHA.
Industry payments across TX — which companies pay providers there.
